BioSpace News Archive

BioForest

Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for Clinical Development Guidance of CDI-45205 for COVID-19 Treatment

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the submission of a pre-Investigational New Drug (IND) briefing package to the U.S. Food and Drug Administration (FDA) for its broad-spectrum protease inhibitor CDI-45205

November 1, 2021
·
4 min read
Business

BioVie Announces the Appointment of a New Chief Medical OfficerDr. Joseph M. Palumbo, Distinguished Pharma Industry Veteran, to Oversee Development Programs in Neurodegenerative and Liver Disease

BioVie Inc. announced today the appointment of Joseph M. Palumbo, MD, LFAPA, MACPsych, as the Company’s new Chief Medical Officer.

November 1, 2021
·
6 min read
Business

I-Mab Strengthens Senior Executive Team with New Chief Financial Officer and Chief Strategy Officer Appointments

I-Mab (the “Company”) (Nasdaq: IMAB), today announced the appointment of John Long as the Company’s Chief Financial Officer and Jielun Zhu as the Company’s Chief Strategy Officer, both effectively immediately.

November 1, 2021
·
5 min read
Drug Development

Tarveda Therapeutics Announces Data from Phase 2 Trial of PEN-221 to Be Presented at NANETS 2021 Multidisciplinary NET Virtual Symposium

Tarveda Therapeutics, Inc., which it refers to as Pentarin® miniature drug conjugates, today announced that data from the Phase 2 clinical trial of PEN-221 will be presented at the North American Neuroendocrine Tumor Society (NANETS) 2021 Multidisciplinary NET Medical Virtual Symposium occurring November 3-6, 2021.

November 1, 2021
·
2 min read
Business

Lengo Therapeutics Announces Appointment of Brion W. Murray, Ph.D., as Senior Vice President of Research

Lengo Therapeutics, a biopharmaceutical company developing novel precision medicines targeting driver mutations in oncology, today announced the appointment of Brion W. Murray, Ph.D., as Senior Vice President of Research.

November 1, 2021
·
2 min read
Business

Synthekine Establishes Collaboration with Merck to Develop Therapeutic Candidates Using its Proprietary Surrogate Cytokine Agonist Platform

Synthekine Inc. today announced it has entered into a worldwide research collaboration and license agreement with Merck, known as MSD outside the United States and Canada.

November 1, 2021
·
3 min read
Business

Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours

Imugene Ltd and Eureka Therapeutics, Inc. today announced a strategic collaboration to evaluate Imugene’s CD19 oncolytic virus onCARlytics technology in combination with Eureka’s anti-CD19 ARTEMIS® T-cell therapy for the treatment of solid tumours.

November 1, 2021
·
6 min read
Pharm Country

UroGen Pharma to Host Virtual Spotlight Event on November 10, 2021

UroGen Pharma Ltd. today announced that it will host a virtual “Spotlight Event” on Wednesday, November 10, 2021 at 11:00 a.m. Eastern Time.

November 1, 2021
·
2 min read
FDA

Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis

Sio Gene Therapies Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AXO-AAV-GM2, an investigational gene therapy for the treatment of early infantile, late infantile, and juvenile-onset Tay-Sachs and Sandhoff disease.

November 1, 2021
·
6 min read
Policy

Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil

Marrone Bio Innovations, Inc. has submitted the regulatory packages for MBI-306 to the U.S. Environmental Protection Agency (EPA) and for MBI-206 to all three Brazilian regulatory authorities

November 1, 2021
·
5 min read